Home About us Editorial board Ahead of print Browse Articles Search Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1932
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Transcription factor 7-like 2 polymorphism and context-specific risk of metabolic syndrome, type 2 diabetes, and dyslipidemia

Palizban Abbasali, Rezaei Mahnaz, Khanahmad Hossein, Fazilati Mohammad

Year : 2017| Volume: 22| Issue : 1 | Page no: 40-40

   This article has been cited by
1 Genetic polymorphisms in TCF7L2 and PPARG genes and susceptibility to Type 2 diabetes mellitus
Sushma Verma,Neena Srivastava,Monisha Banerjee
Meta Gene. 2021; 28: 100864
[Pubmed]  [Google Scholar] [DOI]
2 TCF7L2 polymorphisms, nut consumption, and the risk of metabolic syndrome: a prospective population based study
Somayeh Hosseinpour-Niazi,Bahar Bakhshi,Asiyeh-Sadat Zahedi,Mahdi Akbarzadeh,Maryam S. Daneshpour,Parvin Mirmiran,Fereidoun Azizi
Nutrition & Metabolism. 2021; 18(1)
[Pubmed]  [Google Scholar] [DOI]
3 Transcription Factor-7-Like-2 (TCF7L2) in Atherosclerosis: A Potential Biomarker and Therapeutic Target
Junyi Li,Li Zhou,Xinping Ouyang,Pingping He
Frontiers in Cardiovascular Medicine. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
4 Physical Activity, Cardiorespiratory Fitness, and the Metabolic Syndrome
Jonathan Myers,Peter Kokkinos,Eric Nyelin
Nutrients. 2019; 11(7): 1652
[Pubmed]  [Google Scholar] [DOI]
5 Narrowband UVB treatment induces expression of WNT7B, WNT10B and TCF7L2 in psoriasis skin
Malin Assarsson,Jan Söderman,Albert Duvetorp,Ulrich Mrowietz,Marita Skarstedt,Oliver Seifert
Archives of Dermatological Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
6 Association of variants rs7903146 and rs290487 of TCF7L2 gene with diabetic nephropathy and co-morbidities (hypertension and dyslipidemia) in type 2 diabetes mellitus
Shania Abidi Nee Abbas,Syed Tasleem Raza,Snober S. Mir,Zeba Siddiqi,Alina Zaidi,ZeashanHaider Zaidi,Farzana Mahdi
Meta Gene. 2019; 20: 100561
[Pubmed]  [Google Scholar] [DOI]
7 Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management
Yingmei Zhang,Adam T. Whaley-Connell,James R. Sowers,Jun Ren
Pharmacology & Therapeutics. 2018;
[Pubmed]  [Google Scholar] [DOI]
8 Protective effects of allicin on 1,3-DCP-induced lipid metabolism disorder in HepG2 cells
Jing Lu,Bijun cheng,Baochen Fang,Zhuoqun Meng,Yiying Zheng,Xiaochen Tian,Shuang Guan
Biomedicine & Pharmacotherapy. 2017;
[Pubmed]  [Google Scholar] [DOI]
E M Zelenskaya,N V Kokh,A A Slepukhina,G I Lifshits
Clinical Practice. 2017; 8(3): 76
[Pubmed]  [Google Scholar] [DOI]


Read this article